Catapult Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-3,178
Closed -$182K 248
2014
Q2
$182K Buy
+3,178
New +$182K 0.02% 157